Yingfu Li,Haoxi Huang,Guanfeng Liu,Tonghui Chen,Junfeng Ren,Zhonghai Su
申请号：
US16468658
公开号：
US10793576B2
申请日:
2017.02.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides a compound having a structure shown in formula (I) or an isomer, pharmaceutically acceptable solvate, or salt thereof. The compound is used as a Bruton's tyrosine kinase inhibitor, and has a higher inhibitory activity against BTK and less adverse effects.
